NCT04789876

Brief Summary

This multi-centred randomized, open label-controlled trial consists of hemodialysis (HD) patients identified with hyperphosphatemia (\>1.78mmol/L). The intervention group received a phosphate mobile app and the control group received one-off dietary counselling for 12 weeks. Serum phosphate was measured pre-and post-intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 29, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 29, 2020

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

March 2, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 10, 2021

Completed
Last Updated

March 10, 2021

Status Verified

March 1, 2021

Enrollment Period

4 months

First QC Date

March 2, 2021

Last Update Submit

March 8, 2021

Conditions

Keywords

HemodialysisHyperphosphatemiaMobile appDietary counselingSerum phosphorusPhosphate knowledgeDietary intakePhosphate binder adherence

Outcome Measures

Primary Outcomes (1)

  • Changes in serum phosphorus

    Effect of intervention on serum phosphorus

    Baseline, 12 weeks

Secondary Outcomes (3)

  • Changes in phosphate knowledge

    Baseline, 12 weeks

  • Changes in dietary intake

    Baseline, 12 weeks

  • Changes in phosphate binder adherence

    Baseline, 12 weeks

Study Arms (2)

App Intervention Group (AIG)

EXPERIMENTAL

Phosphate mobile app for 12 weeks.

Other: Phosphate mobile app

Dietitian Intervention Group (DIG)

ACTIVE COMPARATOR

One-off 45-minute dietary counselling delivered by a dietitian at the baseline of the study.

Behavioral: One-off dietary counselling with a phosphate booklet

Interventions

The phosphate mobile app has the features of i) matching phosphate binder with dietary phosphate intake, ii) educational videos of phosphate management, iii) food database with local food items, iv) record-keeping and goal setting.

Also known as: MyKidneyDiet - Phosphate Tracker
App Intervention Group (AIG)

One-off 45-minute dietary counselling delivered by a dietitian at the baseline of the study. Patients received a complimentary phosphate booklet after the counselling session. The phosphate booklet contains similar educational information as per the phosphate mobile app excluding the matching of phosphate binder with dietary phosphate information.

Dietitian Intervention Group (DIG)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years old and above.
  • Patients were undergoing maintenance HD treatment for more than three months.
  • Patients were on hemodialysis treatment for 4 hours per session, three times a week.
  • Kt/V value (a numerical formula value to determine hemodialysis treatment adequacy. K is dialyser clearance of urea, t is dialysis time, and V is the volume of distribution of urea, approximately equal to the patient's total body water) is 1.2 and above each session.
  • Patients were able to read English or Malay or Mandarin.
  • Patients were on the single type of phosphate binder.
  • Patients were having serum phosphorus above 1.78mmol/l and above for more than three months.
  • Patients were not seen by a dietitian for the past one year for phosphate education.
  • Patients did not have ward admission for the past three months.
  • Patients did not have dementia or developmental delay.
  • Patients owned and able to use a smartphone.
  • Patients were able to use at least one comprehensive mobile application independently.
  • Patients had access to the internet/data plan.
  • Patients were willing to adhere to all study requirements and protocol.
  • Patients were willing to accept the publication of data without exposing their name.

You may not qualify if:

  • Patients were on incremental or acute hemodialysis.
  • Patients had ward admission three months prior to the study and during the study period.
  • Patients were terminally ill.
  • Patients had cognitive impairment or physical disabilities (visual, hand dexterity, etc.) hindering interview and PMA utilisation.
  • Patients had visual impairment or blind hindering the interview or the use of PMA.
  • Patients were unable to self-care and dependent.
  • Patients stayed in an institutionalised setting.
  • Patients had undergone parathyroidectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Pusat Rawatan Dialisis Islah

Batu Caves, Selangor, 68100, Malaysia

Location

National Kidney Foundation Malaysia

Petaling Jaya, Selangor, 46100, Malaysia

Location

Hospital Kuala Lumpur

Kuala Lumpur, 50586, Malaysia

Location

Related Publications (8)

  • Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB. Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update. Ann Intern Med. 2018 Mar 20;168(6):422-430. doi: 10.7326/M17-2640. Epub 2018 Feb 20.

    PMID: 29459980BACKGROUND
  • Umeukeje EM, Mixon AS, Cavanaugh KL. Phosphate-control adherence in hemodialysis patients: current perspectives. Patient Prefer Adherence. 2018 Jul 4;12:1175-1191. doi: 10.2147/PPA.S145648. eCollection 2018.

    PMID: 30013329BACKGROUND
  • Chan MW, Cheah HM, Mohd Padzil MB. Multidisciplinary education approach to optimize phosphate control among hemodialysis patients. Int J Clin Pharm. 2019 Oct;41(5):1282-1289. doi: 10.1007/s11096-019-00878-4. Epub 2019 Jul 13.

  • Milazi M, Bonner A, Douglas C. Effectiveness of educational or behavioral interventions on adherence to phosphate control in adults receiving hemodialysis: a systematic review. JBI Database System Rev Implement Rep. 2017 Apr;15(4):971-1010. doi: 10.11124/JBISRIR-2017-003360.

  • Fakih El Khoury C, Crutzen R, Schols JMGA, Halfens RJG, Karavetian M. A Dietary Mobile App for Patients Undergoing Hemodialysis: Prospective Pilot Study to Improve Dietary Intakes. J Med Internet Res. 2020 Jul 20;22(7):e17817. doi: 10.2196/17817.

  • Elder GJ, Malik A, Lambert K. Role of dietary phosphate restriction in chronic kidney disease. Nephrology (Carlton). 2018 Dec;23(12):1107-1115. doi: 10.1111/nep.13188.

  • Reddy V, Symes F, Sethi N, Scally AJ, Scott J, Mumtaz R, Stoves J. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population. J Ren Nutr. 2009 Jul;19(4):314-20. doi: 10.1053/j.jrn.2008.11.001.

  • Vrdoljak I, Panjkota Krbavcic I, Bituh M, Leko N, Pavlovic D, Vrdoljak Margeta T. The impact of education and cooking methods on serum phosphate levels in patients on hemodialysis: 1-year study. Hemodial Int. 2017 Apr;21(2):256-264. doi: 10.1111/hdi.12468. Epub 2016 Aug 16.

MeSH Terms

Conditions

Hyperphosphatemia

Condition Hierarchy (Ancestors)

Phosphorus Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Tilakavati Karupaiah, PhD

    Taylor's University

    PRINCIPAL INVESTIGATOR
  • Teong Lee Fang, BSc

    Taylor's University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients were allocated to the intervention and control group. The intervention group received a phosphate mobile app for 12 weeks and the control group received one-off dietary counselling delivered by a dietitian with a phosphate booklet.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
SRI Professor

Study Record Dates

First Submitted

March 2, 2021

First Posted

March 10, 2021

Study Start

November 1, 2019

Primary Completion

February 29, 2020

Study Completion

February 29, 2020

Last Updated

March 10, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations